期刊文献+

抗肿瘤药物的研究新进展 被引量:35

NEW RESEARCH APPROACHES IN ANTI TUMOR DRUG
下载PDF
导出
摘要 综述和分析了抗肿瘤药物近年来的新进展 ,包括细胞毒性抗肿瘤药物、以细胞信号转导分子为靶点的抗肿瘤药物、新生血管生成抑制剂、耐药逆转剂、反义药物。 Recent developments and approaches in anti tumor drug were reviewed and analysed in this manuscript, including new agents of traditional cytotoxity, protein tyrosine kinase inhibitors, farnesyltransferase inhibitors, tumor angiogenesis inhibitors, resistance reversal agents, antisense oligodeoxyribonucleotides, telomerase inhibitors and so forth.
作者 丁健
出处 《中国新药杂志》 CAS CSCD 2000年第3期149-154,共6页 Chinese Journal of New Drugs
关键词 抗肿瘤药物 细胞毒性 拓扑异构酶 酪氨酸激酶 Anti tumor drug Cytotoxicity Topoisomerase Tyosine kinase Farnesyltransferase Angiogenesis Telomerase
  • 相关文献

参考文献42

  • 11,Georgoulias, Crown JP.Increasing options in cancer therapy: current status and future prospects. Anti CancerDrugs, 1999,10(Suppl 1)∶S1
  • 22,Christian MC, Pluda JM, Ho PTC, et al. Promising new agents under development by thedivision of cancer treatment, diagnosis and centers of the national cancer institute.Semin Oncol, 1997, 24∶219
  • 33,Kollmannsberger C, Mross K, Jakob A, et al. Topotecan—a novel topoisomerase Iinhibitor: pharmacology and clinical experience. Oncology, 1999,56∶1
  • 44,Armand JP, Cunningham D, Cutsem E, et al. Clinical advances with topoisomerase Iinhibitors in gastrointestinal malignancies. Anti Cancer Drugs, 1999, 10(Suppl 12)∶S5
  • 55,Sandler A, Oosterom AT. Irinotecan in cancer of the lung and cervix. Anti CancerDrugs, 1999, 10(Suppl 1)∶S13
  • 66,Redinbo MR, Stewart L, Kuhn P, et al. Crystal structure of human topoisomerase I incovalent and noncovalent complexes with DNA. Science, 1998,279∶1504
  • 77,Stewart L, Redinbo MR, Qiu X, et al. A model for the mechanism of human topoisomeraseI. Science, 1998,279∶1534
  • 88,Kraus-Berthier L, Guilband N, Jan M, et al. Experimental antitumor activity ofS-16020-2 in a panel of human tumors. Eur J Cancer, 1997,33∶1881
  • 99,Guilbaud N, Kraus-Berthier L, Saint-Dizier D, et al. In vivo antitumor activity ofs-16020-2, a new olivacine derivative. Cancer Chemother Pharmacol, 1996, 38∶513
  • 1010,Lemee S, Pierre A, Markovits J, et al. S-16020-2, a new highly cytotoxic antitumorolivacine derivative: DNA interaction and DNA topoisomerase II inhibition. Mol Pharmacol,1998, 53∶213

共引文献87

同被引文献407

引证文献35

二级引证文献274

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部